Protein kinases are highly evolved signal transduction enzymes that regulate almost every biological process known. In the immune system, kinases control the ability to differentiate self from non-self. Autoimmune disorders such as arthritis, some forms of diabetes, organ-transplant rejection, and other conditions are known to result from aberrant regulation of protein kinase pathways. Yet, drugs which target protein kinases to treat these disorders have been difficult to develop because of the ubiquitous and highly conserved active sites of protein kinases.Through development of a chemical genetic strategy, it has become possible to create the first mono-specific inhibitors of any protein kinases and to use these reagents to study the effects of specific kinase inhibitors on T cell signal transduction. These reagents have revealed the presence of previously unexpected thresholds of kinase activity which are required for signaling. The current proposal seeks to quantify these thresholds by measurement of the quantitative dependence of T cell receptor signal transduction on the catalytic activity of three receptor proximal kinases, Lck, Fyn, and Zap-70. A novel chemical genetic approach will be used to reveal the activity of a single kinase in the T cell necessary for downstream T cell signal transduction events such as interleukin-2 (IL-2) production. A quantitative map of T cell signal transduction will allow for precise selection of the best kinase targets for drug discovery toward the treatment of many autoimmune disorders which result from aberrant T cell signaling.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI044009-08
Application #
6792634
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Program Officer
Mallia, Conrad M
Project Start
1998-09-01
Project End
2007-08-31
Budget Start
2004-09-01
Budget End
2005-08-31
Support Year
8
Fiscal Year
2004
Total Cost
$376,200
Indirect Cost
Name
University of California San Francisco
Department
Pharmacology
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Burkard, Mark E; Maciejowski, John; Rodriguez-Bravo, VerĂ³nica et al. (2009) Plk1 self-organization and priming phosphorylation of HsCYK-4 at the spindle midzone regulate the onset of division in human cells. PLoS Biol 7:e1000111
Justman, Quincey A; Serber, Zach; Ferrell Jr, James E et al. (2009) Tuning the activation threshold of a kinase network by nested feedback loops. Science 324:509-12
Niu, Hengyao; Wan, Lihong; Busygina, Valeria et al. (2009) Regulation of meiotic recombination via Mek1-mediated Rad54 phosphorylation. Mol Cell 36:393-404
Apsel, Beth; Blair, Jimmy A; Gonzalez, Beatriz et al. (2008) Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases. Nat Chem Biol 4:691-9
Bateman, Raynard L; Rauh, Daniel; Tavshanjian, Brandon et al. (2008) Human carbonyl reductase 1 is an S-nitrosoglutathione reductase. J Biol Chem 283:35756-62
Johnson, Alexander W; Chen, Xi; Crombag, Hans S et al. (2008) The brain-derived neurotrophic factor receptor TrkB is critical for the acquisition but not expression of conditioned incentive value. Eur J Neurosci 28:997-1002
Rubenstein, Eric M; McCartney, Rhonda R; Zhang, Chao et al. (2008) Access denied: Snf1 activation loop phosphorylation is controlled by availability of the phosphorylated threonine 210 to the PP1 phosphatase. J Biol Chem 283:222-30
Park, S; Chapuis, N; Bardet, V et al. (2008) PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML. Leukemia 22:1698-706
Kurischko, Cornelia; Kuravi, Venkata K; Wannissorn, Nattha et al. (2008) The yeast LATS/Ndr kinase Cbk1 regulates growth via Golgi-dependent glycosylation and secretion. Mol Biol Cell 19:5559-78
Shirra, Margaret K; McCartney, Rhonda R; Zhang, Chao et al. (2008) A chemical genomics study identifies Snf1 as a repressor of GCN4 translation. J Biol Chem 283:35889-98

Showing the most recent 10 out of 47 publications